Mycobacterium chimaera Encephalitis Following Cardiac Surgery: A New Syndrome.

Mycobacterium chimaera cardiopulmonary bypass granulomatous encephalitis infection prevention and control post operative infections

Journal

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
ISSN: 1537-6591
Titre abrégé: Clin Infect Dis
Pays: United States
ID NLM: 9203213

Informations de publication

Date de publication:
03 02 2020
Historique:
received: 14 12 2018
accepted: 17 06 2019
pubmed: 28 6 2019
medline: 7 1 2021
entrez: 28 6 2019
Statut: ppublish

Résumé

We report the cases of 3 patients with fatal, disseminated Mycobacterium chimaera infections following cardiac surgeries. Progressive neurocognitive decline and death were explained by active granulomatous encephalitis, with widespread involvement of other organs. This syndrome is clinically elusive and, thus, may have caused deaths in prior reported series.

Identifiants

pubmed: 31247065
pii: 5521024
doi: 10.1093/cid/ciz497
doi:

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

692-695

Informations de copyright

© The Author(s) 2019. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Auteurs

Darren Lau (D)

Division of General Internal Medicine, University of Alberta, Edmonton, Canada.

Ryan Cooper (R)

Division of Infectious Diseases, University of Alberta, Edmonton, Canada.

Justin Chen (J)

Division of Infectious Diseases, University of Alberta, Edmonton, Canada.

Valerie L Sim (VL)

Division of Neurology, Department of Medicine, University of Alberta, Edmonton, Canada.

Jennifer A McCombe (JA)

Division of Neurology, Department of Medicine, University of Alberta, Edmonton, Canada.

Gregory J Tyrrell (GJ)

Provincial Laboratory for Public Health, University of Alberta, Edmonton, Canada.
Division of Diagnostic and Applied Microbiology, Department of Laboratory Medicine and Pathology, University of Alberta, Edmonton, Canada.

Ravi Bhargava (R)

Department of Radiology and Diagnostic Imaging, University of Alberta, Edmonton, Canada.

Benjamin Adam (B)

Division of Anatomical Pathology, Department of Laboratory Medicine and Pathology, University of Alberta, Canada.

Erin Chapman (E)

Division of Anatomical Pathology, Department of Laboratory Medicine and Pathology, University of Alberta, Canada.

Matthew A Croxen (MA)

Provincial Laboratory for Public Health, University of Alberta, Edmonton, Canada.
Division of Diagnostic and Applied Microbiology, Department of Laboratory Medicine and Pathology, University of Alberta, Edmonton, Canada.

Cherif Garady (C)

Division of Anatomical Pathology, Department of Laboratory Medicine and Pathology, University of Alberta, Canada.

Kym Antonation (K)

National Microbiology Laboratory, Winnipeg, Manitoba, University of Alberta, Edmonton, Canada.

Frank K H van Landeghem (FKH)

Division of Anatomical Pathology, Department of Laboratory Medicine and Pathology, University of Alberta, Canada.
Neuroscience and Mental Health Institute, University of Alberta, Edmonton, Canada.

Shannon Ip (S)

Division of General Internal Medicine, University of Alberta, Edmonton, Canada.

Lynora Saxinger (L)

Division of Infectious Diseases, University of Alberta, Edmonton, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH